NewAmsterdam Pharma Co N.V annual operating margin
2022
2023
2024
2025
NewAmsterdam Pharma Co N.V's operating margin was −1,002.90% for fiscal 2025.
View full NewAmsterdam Pharma Co N.V company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,002.90% | −615.99 pp |
| 2024 | 2024-12-31 | −386.91% | +911.65 pp |
| 2023 | 2023-12-31 | −1,298.56% | −1295.10 pp |
| 2022 | 2022-12-31 | −3.46% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,752.61% | −1566.48 pp |
| Q1 2026 | 2026-03-31 | −1,921.71% | +392.76 pp |
| Q4 2025 | 2025-12-31 | −206,187.50% | −205849.03 pp |
| Q3 2025 | 2025-09-30 | −15,845.69% | −15759.80 pp |
| Q2 2025 | 2025-06-30 | −186.13% | +2120.80 pp |
| Q1 2025 | 2025-03-31 | −2,314.47% | +1645.70 pp |
| Q4 2024 | 2024-12-31 | −338.47% | +6021.93 pp |
| Q3 2024 | 2024-09-30 | −85.89% | +1599.18 pp |
| Q2 2024 | 2024-06-30 | −2,306.93% | +167.27 pp |
| Q1 2024 | 2024-03-31 | −3,960.17% | −3498.32 pp |
| Q4 2023 | 2023-12-31 | −6,360.40% | — |
| Q3 2023 | 2023-09-30 | −1,685.07% | — |
| Q2 2023 | 2023-06-30 | −2,474.20% | — |
| Q1 2023 | 2023-03-31 | −461.85% | — |
Across the available reported history, NewAmsterdam Pharma Co N.V's operating margin decreased from −386.91% to −1,002.90%, a change of −615.99 percentage points. The latest reported quarter, Q2 2026, shows −1,752.61%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewAmsterdam Pharma Co N.V filings at SEC.gov ↗